News
CRISPR Therapeutics has begun realizing sales on Casgevy, its first therapy and a joint venture with Vertex Pharmaceuticals. The company has plenty of cash to fund research and development for the ...
NEW YORK and CAMBRIDGE, England, May 1, 2025 /PRNewswire/ -- Intima Bioscience, a clinical stage oncology company focused on curative intent in solid tumor cancers, presented data from a ...
CRISPR-Cascade, including sample preparation, requires about half an hour, making it the fastest available bloodstream infection diagnostic. There is also the potential to improve sample prep ...
Therefore, using CRISPR-Cas9 technology, they deleted the CD5 gene in CAR T cells, so the engineered cells wouldn't attack each other. This knockout of CD5 in the CAR T cells turned out to provide ...
have recently developed a novel vaccine candidate against the genotype IX strain of the African swine fever virus (ASFV) using a CRISPR-enabled gene deletion method. By knocking out a key section ...
Scientists introduced CRISPR to the world as a gene-editing tool in summer 2012, when landmark papers from two independent groups demonstrated how the system could be wielded to make cuts in DNA.
Schematic of the CRISPR/Cas9 system and its nanotechnology delivery methods. The CRISPR/Cas9 system can be delivered in the forms of DNA, mRNA/sgRNA, or ribonucleoprotein (RNP).
It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This November, the United Kingdom authorized the first medical treatment using Crispr gene ...
CRISPR Therapeutics laid off a number of employees a week after FDA advisers all but greenlighted the company’s Vertex-partnered, CRISPR-edited sickle cell therapy, sources told Fierce Biotech.
Schematic representation of the SLC‐focused CRISPR knockout screen in the LRP8 wild‐type and ... Cell lines were tested for identity by SNP genotyping and mycoplasma contamination by the respective ...
Most commonly, CRISPR knockout is used, but CRISPR activation ... providing a clearer picture of the relationship between the genotype and phenotype. A third option is single-cell CRISPR screening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results